Jafron Biomedical: Announcement on the determination of the 2023 remuneration of directors, supervisors and senior management and the 2024 remuneration plan

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.